March 12 (Reuters) - 2cureX AB 2CUREX.ST :
* 2CUREX EXPANDS ITS ACTIVITIES TO PREVENTIVE CANCER
MEDICINE
* TOGETHER WITH UNIVERSITY HOSPITAL BISPEBJERG (COPENHAGEN,
DENMARK) ARE LAUNCHING A FEASIBILITY STUDY TO USE INDITREAT®
TEST
* TOGETHER WITH UNIVERSITY HOSPITAL BISPEBJERG (COPENHAGEN,
DENMARK) ARE LAUNCHING A FEASIBILITY STUDY TO USE INDITREAT®
TEST
* A SUCCESSFUL INDITREAT® STUDY WILL OPEN FOR LARGE SCALE
GENERAL
TESTING FOR IDENTIFICATION OF PREVENTIVE CANCER TREATMENT
DESIGNED FOR INDIVIDUAL ADENOMA PATIENT
* TO IDENTIFY EXISTING OR NOVEL DRUGS THAT CAN PREVENT
CANCER
PRECURSORS TO DEVELOP INTO FULL-BLOWN COLORECTAL CANCER
Source text for Eikon: ID:nWkr6l5f4n
Further company coverage: 2CUREX.ST
(Gdynia Newsroom)
((gdynia.newsroom@thomsonreuters.com; +48 58 772 0920;))